Networked Healthcare
As different stakeholder groups across the healthcare delivery landscape become more interdependent, influence and decision patterns become increasingly dynamic and more difficult to see and predict.
There is increasing evidence that pharmaceutical companies who understand the dynamics of the network, as a whole, create a strategic advantage compared to their competitors who continue to focus on a physician-centered prescribing model.
“Early movers” to adopt network intelligence will generate significant competitive advantage in three areas: deeper collaboration potential, superior value propositions, and enhanced influence and image.